Review of long-term immunogenicity following HPV vaccination

Autor: TM Schurink-van 't Klooster, Hella Pasmans, R. Donken, J Hoes, H.E. de Melker, F.R.M. van der Klis, Johannes Berkhof
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Hoes, J, Pasmans, H, Schurink-van 't Klooster, T M, van der Klis, F R M, Donken, R, Berkhof, J & de Melker, H E 2021, ' Review of long-term immunogenicity following HPV vaccination : Gaps in current knowledge ', Human Vaccines & Immunotherapeutics, pp. 1-11 . https://doi.org/10.1080/21645515.2021.1908059
ISSN: 2164-5515
Popis: The licensed HPV vaccines are highly efficacious and induce high levels of neutralizing antibody levels, the assumed mediators of protection. However, a correlate of protection against HPV is lacking, and the evidence is still limited as to long-term persistence of antibodies, especially following reduced dosing schedules. The World Health Organization (WHO) urges immunization of young girls as part of the strategy to eliminate cervical cancer, thus long-lasting protection is required. The current review describes long-term follow-up regarding vaccine-induced seropositivity and antibody level development following the different vaccines and dosing schedules. Implications and opportunities of long-term vaccine-induced immune responses are discussed, such as the gaps in monitoring of long-term immunogenicity, the possibilities of reduced dosing schedules, and the importance of evidence for durable immunity.
Databáze: OpenAIRE